Brought to you by 
Invitae nets $184.9mm in FOPO
07 Mar 2019
Executive Summary
Genetic testing firm Invitae Corp. netted $184.9mm via a follow-on public offering of 10.35mm common shares (including full exercise of the overallotment) at $19 each.
Deal Industry
- In Vitro Diagnostics
- Laboratory Testing Services
- Research, Analytical Equipment & Supplies
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Invitae nets $184.9mm in FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice